Search

Now showing items 1-10 of 133

The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction

Jones, DA; Rathod, KS; Williamson, A; Harrington, D; Andiapen, M; van Eijl, S; Westwood, M; Antoniou, S; Schilling, RJ; Ahluwalia, A;... (2018-09-01)

Sodium Nitrite-Mediated Cardioprotection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Cost-Effectiveness Analysis.

Jones, DA; Whittaker, P; Rathod, KS; Richards, AJ; Andiapen, M; Antoniou, S; Mathur, A; Ahluwalia, A (2019-03)

OBJECTIVES:: In the follow-up of patients in a trial of intracoronary sodium nitrite given during primary percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI), we found a reduction in the incidence ...

Long-Term Effects of Autologous Bone Marrow Stem Cell Treatment in Acute Myocardial Infarction: Factors That May Influence Outcomes

Clifford, DM; Fisher, SA; Brunskill, SJ; Doree, C; Mathur, A; Clarke, MJ; Watt, SM; Martin-Rendon, E (2012-05-24)

Bone marrow mononuclear cells and acute myocardial infarction

Arnous, S; Mozid, A; Martin, J; Mathur, A (2012-01-17)

Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis

Fisher, SA; Doree, C; Brunskill, SJ; Mathur, A; Martin-Rendon, E (2013-06-19)

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients.

Rathod, KS; Antoniou, S; Avari, P; Ding, N; Wright, P; Knight, C; Jain, AK; Mathur, A; Smith, EJ; Weerackody, R;... (2017-01)

INTRODUCTION: Glycoprotein IIb/IIIa inhibitors are recommended by guidelines in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. There are few studies directly ...

Combined analysis of the safety of intra-coronary drug delivery during primary percutaneous coronary intervention for acute myocardial infarction: A study of three clinical trials.

Rathod, KS; Hamshere, S; Khambata, RS; Andiapen, M; Westwood, M; Mathur, A; Ahluwalia, A; Jones, DA (2017-01)

Background: The local injection of novel cardioprotective study drugs prior to percutaneous coronary intervention could cause embolisation of thrombus, resulting in increased reperfusion injury and subsequent infarct size. ...

The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial

Jones, DA; Andiapen, M; Van-Eijl, TJA; Webb, AJ; Antoniou, S; Schilling, RJ; Ahluwalia, A; Mathur, A (2013)

Out-of-hours primary percutaneous coronary intervention for ST-elevation myocardial infarction is not associated with excess mortality: a study of 3347 patients treated in an integrated cardiac network

Rathod, KS; Jones, DA; Gallagher, SM; Bromage, DI; Whitbread, M; Archbold, AR; Jain, AK; Mathur, A; Wragg, A; Knight, CJ (2013)

Local Hemodynamics An Innocent Bystander or a Critical Factor Regulating Neoatherosclerotic Evolution?

Michail, M; Torii, R; Crake, T; Ozkor, M; Garcia-Garcia, HM; Tenekecioglu, E; Onuma, Y; Mathur, A; Serruys, PW; Bourantas, CV (2015-08-17)

1
2
3
4
. . .
14